Collegium Pharmaceutical, Inc. (COLL) Financials

COLL Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.1 billion 892.1 million
2023-12-31 1.1 billion 947.9 million
2023-09-30 1.2 billion 998.7 million
2023-06-30 1.2 billion 1.0 billion

COLL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 61.4 million 7.5 million
2023-12-31 73.2 million 7.0 million
2023-09-30 74.0 million 7.0 million
2023-06-30 99.7 million 7.1 million

COLL Net Income

No data available :(

COLL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 318.0 million - 6.9 million
2023-12-31 310.5 million - 7.1 million
2023-09-30 304.6 million - 7.3 million
2023-06-30 325.5 million 571.4 million 7.6 million

COLL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 41.4 million
2023-12-31 41.8 million
2023-09-30 42.1 million
2023-06-30 42.8 million

COLL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 568000 - 42.0 million -
2023-12-31 164000 - 25.5 million 7.4 million
2023-09-30 65000 - 35.3 million -
2023-06-30 56000 - 38.2 million -

COLL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 144.9 million 53.5 million
2023-12-31 149.7 million 55.1 million
2023-09-30 136.7 million 56.4 million
2023-06-30 135.5 million 61.7 million

COLL

Price: $33.78

52 week price:
20.83
40.95

Earnings Per Share: 1.29 USD

P/E Ratio: 141.71

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 465500

Ebitda: -13.3 million

Market Capitalization: 1.1 billion

Links: